First Circuit revives Amphastar suit
A lower court misapplied the Noerr-Pennington doctrine in dismissing antitrust claims that two drugmakers conspired to restrict competition for a generic anticoagulant, the US Court of Appeals for the First Circuit held on Monday.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10